Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion
   Dependent (TD) Low Risk Del(5q) - Preliminary Blinded Analysis of the
   European Sintra-REV Trial

Dokumenttyp:: Meeting Abstract
Autor(en):: Lopez Cadenas, Felix; Lumbreras, Eva; Xicoy, Blanca; Sanchez-Garcia, Joaquin; Fenaux, Pierre; Coll, Rosa; Slama, Borhane; Angel Hernandez-Rivas, Jose; Thépot, Sylvain; Bernal, Teresa; Arrizabalaga, Beatriz; Guerci, Agnes; Sanz, Guillermo; Bargay, Joan; Luz Amigo, Maria; de Paz, Raquel; Giagounidis, Aristoteles; Platzbecker, Uwe; Nomdedeu, Benet; Jourdan, Eric; Goetze, Katharina S.; Arar, Ali; Maria Hernandez-Rivas, Jesus; Del Canizo, Consuelo; Diez-Campelo, Maria
Titel:: Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) - Preliminary Blinded Analysis of the European Sintra-REV Trial
Zeitschriftentitel:: Blood
Jahr:: 2018
Band / Volume:: 132
Volltext / DOI:: doi:10.1182/blood-2018-99-119430
Print-ISSN:: 0006-4971
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: